Commonwealth Equity Services
APGE icon

Commonwealth Equity Services’s Apogee Therapeutics APGE Stock Holding History

Commonwealth Equity Services’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$754K Sell
5,683
-232
-4% -$20.9K ﹤0.01% 2950
2026
Q1 		$498K Sell
5,915
-1,236
-17% -$89.8K ﹤0.01% 3210
2025
Q4 		$540K Buy
7,151
+152
+2% +$9.57K ﹤0.01% 3118
2025
Q3 		$278K Buy
6,999
+99
+1% +$3.78K ﹤0.01% 3717
2025
Q2 		$300K Buy
6,900
+398
+6% +$15.1K ﹤0.01% 3580
2025
Q1 		$243K Buy
6,502
+1,596
+33% +$61.7K ﹤0.01% 3674
2024
Q4 		$222K Buy
+4,906
New +$250K ﹤0.01% 3670

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
TMAM
Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Commonwealth Equity Services's APGE Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Apogee Therapeutics (APGE) stake by 3.9% in Q2 2026, selling an estimated $20.9K and leaving 5,683 shares worth $754K. The position accounts for ﹤0.01% of the portfolio, ranked #2950.

Commonwealth Equity Services first reported a position in APGE in Q4 2024 and has held it in 7 quarters since. 36 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Commonwealth Equity Services held 5,683 shares of Apogee Therapeutics worth $754K as of Q2 2026.
  • Commonwealth Equity Services sold 232 Apogee Therapeutics shares in Q2 2026, an estimated $20.9K.
  • Apogee Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2950 holding.
  • Commonwealth Equity Services first reported a position in Apogee Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 36 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.